U.S. markets open in 6 hours 22 minutes
  • S&P Futures

    3,984.75
    +14.50 (+0.37%)
     
  • Dow Futures

    33,939.00
    +68.00 (+0.20%)
     
  • Nasdaq Futures

    11,678.75
    +62.50 (+0.54%)
     
  • Russell 2000 Futures

    1,844.00
    +11.20 (+0.61%)
     
  • Crude Oil

    78.67
    +1.43 (+1.85%)
     
  • Gold

    1,752.40
    +12.10 (+0.70%)
     
  • Silver

    21.22
    +0.30 (+1.46%)
     
  • EUR/USD

    1.0377
    +0.0032 (+0.31%)
     
  • 10-Yr Bond

    3.7030
    0.0000 (0.00%)
     
  • Vix

    22.21
    +1.71 (+8.34%)
     
  • GBP/USD

    1.2031
    +0.0066 (+0.55%)
     
  • USD/JPY

    138.1530
    -0.7480 (-0.54%)
     
  • BTC-USD

    16,468.72
    +251.29 (+1.55%)
     
  • CMC Crypto 200

    388.61
    +8.31 (+2.19%)
     
  • FTSE 100

    7,474.02
    0.00 (0.00%)
     
  • Nikkei 225

    28,027.84
    -134.99 (-0.48%)
     

Why iSpecimen Shares Are Gaining Today?

  • iSpecimen Inc (NASDAQ: ISPC) has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research.

  • The new suppliers include a cancer-focused biobank in the U.S., which contains a differentiated range of pre-and post-treatment tissue and biofluids across multiple cancer types.

  • These samples provide rich genetic, treatment, follow-up, and outcome information.

  • Additionally, iSpecimen has retained a European biobank with a vast urine and blood sample inventory from healthy participants aged 45 to 75, collected with participant health data generated from questionnaires and disease diagnoses.

  • This biobank contains vital early-onset cancer and cardiovascular disease samples, as well.

  • iSpecimen offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers with access to patients and specimens needed for medical discovery.

  • Price Action: ISPC shares are up 21.50% at $2.88 during the market session on the last check Thursday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.